This report provides an analysis of patents covering medicines in trials to treat COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in...

The objective of this research is to learn about the status of patent applications for monoclonal antibodies (mAbs). The paper analyzes the different claim strategies used by applicants to obtain patent protection. The database constructed and described in South Centre Research Paper No. 186 was...

This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...